Skip to main content
. 2023 May 22;13(5):e067083. doi: 10.1136/bmjopen-2022-067083

Table 1.

SARS-CoV-2, malaria and HIV epidemiology in study countries

Country Site SARS-CoV-2-reported cases (country level) Plasmodium falciparum infection prevalence in women at delivery* HIV prevalence in pregnant women
Mozambique Manhiça 228 0001 6% 29%14
Gabon Lambaréné 48 0001 11% 6%15
Libreville NI 6%15

*Data from 2010 to 2012 in women receiving either two IPTp doses of mefloquine or SP (Tuikue-Ndam et al, unpublished).

IPTp, intermittent preventive treatment in pregnancy; NI, no information; SP, sulfadoxine-pyrimethamine.